Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,261,596
+$43,110 QoQ
Shares Held
8,050
+0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#560
of 1,603 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valmark Advisers, Inc. holds $25,445,603 across 11 Drug Manufacturers - General names. NVS ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,846 | $7,011,868 | |
| 2 | JNJ |
Johnson & Johnson
|
23,608 | $5,995,723 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,899 | $3,456,521 | |
| 4 | AMGN |
Amgen Inc
|
8,535 | $3,090,694 | |
| 5 | ABBV |
AbbVie Inc.
|
10,340 | $2,601,957 | |
| 6 | NVS |
Novartis AG
This page
|
8,050 | $1,261,596 | |
| 7 | PFE |
Pfizer Inc
|
33,525 | $807,282 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,261 | $411,994 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,261,596 | 8,050 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,218,486 | 7,977 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,213,531 | 8,802 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,118,894 | 8,725 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $1,066,461 | 8,813 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $980,355 | 8,794 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $856,911 | 8,806 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $961,452 | 8,359 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $897,031 | 8,426 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $802,085 | 8,292 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $832,396 | 8,244 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $839,835 | 8,245 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $747,036 | 7,403 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $699,660 | 7,605 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $674,049 | 7,430 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $565,970 | 7,446 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $618,675 | 7,319 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $651,719 | 7,427 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $649,639 | 7,427 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $647,370 | 7,916 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $752,182 | 8,244 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $691,191 | 8,086 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $705,486 | 7,471 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $281,663 | 3,239 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $356,259 | 4,079 | Shares | Sole | 2020-07-31 | |
| No filing history on record for this holder in this stock. | ||||||